-
1
-
-
84939262035
-
Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence
-
PID: 25936649
-
Simó R, Hernández C (2015) Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence. Prog Retin Eye Res 48:160–180
-
(2015)
Prog Retin Eye Res
, vol.48
, pp. 160-180
-
-
Simó, R.1
Hernández, C.2
-
2
-
-
84959128132
-
The progress in understanding and treatment of diabetic retinopathy
-
PID: 26297071
-
Stitt AW, Curtis TM, Chen M et al (2016) The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res 51:156–186
-
(2016)
Prog Retin Eye Res
, vol.51
, pp. 156-186
-
-
Stitt, A.W.1
Curtis, T.M.2
Chen, M.3
-
3
-
-
84867094327
-
Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications
-
PID: 22887976
-
Simó R, Hernández C, European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR) (2012) Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications. Br J Ophthalmol 96:1285–1290
-
(2012)
Br J Ophthalmol
, vol.96
, pp. 1285-1290
-
-
Simó, R.1
Hernández, C.2
-
4
-
-
84859012407
-
Diabetic retinopathy
-
COI: 1:CAS:528:DC%2BC38XlsVClu7Y%3D, PID: 22455417
-
Antonetti DA, Klein R, Gardner TW (2012) Diabetic retinopathy. N Engl J Med 366:1227–1239
-
(2012)
N Engl J Med
, vol.366
, pp. 1227-1239
-
-
Antonetti, D.A.1
Klein, R.2
Gardner, T.W.3
-
5
-
-
84898432100
-
Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment
-
COI: 1:CAS:528:DC%2BC2cXpsFCgurc%3D, PID: 24673341
-
Abcouwer SF, Gardner TW (2014) Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment. Ann N Y Acad Sci 1311:174–190
-
(2014)
Ann N Y Acad Sci
, vol.1311
, pp. 174-190
-
-
Abcouwer, S.F.1
Gardner, T.W.2
-
6
-
-
84890989082
-
Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives
-
PID: 24183659
-
Simó R, Hernández C, European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR) (2014) Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives. Trends Endocrinol Metab 25:23–33
-
(2014)
Trends Endocrinol Metab
, vol.25
, pp. 23-33
-
-
Simó, R.1
Hernández, C.2
-
7
-
-
36048980250
-
Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration
-
COI: 1:CAS:528:DC%2BD2sXhtlKhs7vI, PID: 17704349
-
Carrasco E, Hernández C, Miralles A, Huguet P, Farrés J, Simó R (2007) Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration. Diabetes Care 30:2902–2908
-
(2007)
Diabetes Care
, vol.30
, pp. 2902-2908
-
-
Carrasco, E.1
Hernández, C.2
Miralles, A.3
Huguet, P.4
Farrés, J.5
Simó, R.6
-
8
-
-
70949094028
-
Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy
-
PID: 19823802
-
Garcia-Ramírez M, Hernández C, Villarroel M et al (2009) Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy. Diabetologia 52:2633–2641
-
(2009)
Diabetologia
, vol.52
, pp. 2633-2641
-
-
Garcia-Ramírez, M.1
Hernández, C.2
Villarroel, M.3
-
9
-
-
84962147366
-
Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes
-
PID: 26384381
-
Hernández C, Bogdanov P, Corraliza L et al (2016) Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes. Diabetes 65:172–187
-
(2016)
Diabetes
, vol.65
, pp. 172-187
-
-
Hernández, C.1
Bogdanov, P.2
Corraliza, L.3
-
10
-
-
35748957503
-
The physiology of glucagon-like peptide 1
-
COI: 1:CAS:528:DC%2BD2sXhtlaqu7jI, PID: 17928588
-
Holst JJ (2007) The physiology of glucagon-like peptide 1. Physiol Rev 87:1409–1439
-
(2007)
Physiol Rev
, vol.87
, pp. 1409-1439
-
-
Holst, J.J.1
-
11
-
-
84883235805
-
Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes
-
PID: 23474487
-
Hernández C, García-Ramírez M, Corraliza L et al (2013) Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes. Diabetes 62:2569–2578
-
(2013)
Diabetes
, vol.62
, pp. 2569-2578
-
-
Hernández, C.1
García-Ramírez, M.2
Corraliza, L.3
-
12
-
-
4344652909
-
Standard for clinical electroretinography (2004 update)
-
PID: 15455793
-
Marmor MF, Holder GE, Seeliger MW, Yamamoto S, International Society for Clinical Electrophysiology of Vision (2004) Standard for clinical electroretinography (2004 update). Doc Ophthalmol 108:107–114
-
(2004)
Doc Ophthalmol
, vol.108
, pp. 107-114
-
-
Marmor, M.F.1
Holder, G.E.2
Seeliger, M.W.3
Yamamoto, S.4
-
13
-
-
84901319791
-
The db/db mouse: a useful model for the study of diabetic retinal neurodegeneration
-
PID: 24837086
-
Bogdanov P, Corraliza L, Villena JA et al (2014) The db/db mouse: a useful model for the study of diabetic retinal neurodegeneration. PLoS One 9:e97302
-
(2014)
PLoS One
, vol.9
-
-
Bogdanov, P.1
Corraliza, L.2
Villena, J.A.3
-
14
-
-
80053946788
-
Glial and endothelial blood-retinal barrier responses to amyloid-beta in the neural retina of the rat
-
COI: 1:CAS:528:DC%2BD1MXjt1Chu7o%3D, PID: 19668434
-
Anderson PJ, Watts H, Hille C et al (2008) Glial and endothelial blood-retinal barrier responses to amyloid-beta in the neural retina of the rat. Clin Ophthalmol 2:801–816
-
(2008)
Clin Ophthalmol
, vol.2
, pp. 801-816
-
-
Anderson, P.J.1
Watts, H.2
Hille, C.3
-
15
-
-
0035096388
-
Sensitive blood–retinal barrier breakdown quantitation using Evans blue
-
COI: 1:STN:280:DC%2BD3M7lt1CitA%3D%3D, PID: 11222542
-
Xu Q, Qaum T, Adamis AP (2001) Sensitive blood–retinal barrier breakdown quantitation using Evans blue. Invest Ophthalmol Vis Sci 42:789–794
-
(2001)
Invest Ophthalmol Vis Sci
, vol.42
, pp. 789-794
-
-
Xu, Q.1
Qaum, T.2
Adamis, A.P.3
-
16
-
-
0037250362
-
Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood-retinal barrier and upregulation of cellular adhesion molecules
-
Xu H, Forrester JV, Liversidge J, Crane I (2003) Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood-retinal barrier and upregulation of cellular adhesion molecules. J Invest Ophthalmol Vis Sci 44:226–234
-
(2003)
J Invest Ophthalmol Vis Sci
, vol.44
, pp. 226-234
-
-
Xu, H.1
Forrester, J.V.2
Liversidge, J.3
Crane, I.4
-
17
-
-
78149441695
-
Betacellulin induces increased retinal vascular permeability in mice
-
PID: 20976146
-
Anand-Apte B, Ebrahem Q, Cutler A et al (2010) Betacellulin induces increased retinal vascular permeability in mice. PLoS One 5:e13444
-
(2010)
PLoS One
, vol.5
-
-
Anand-Apte, B.1
Ebrahem, Q.2
Cutler, A.3
-
18
-
-
84862520770
-
Fiji: an open-source platform for biological-image analysis
-
COI: 1:CAS:528:DC%2BC38XhtVKnurbJ, PID: 22743772
-
Schindelin J, Arganda-Carreras I, Frise E et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676–682
-
(2012)
Nat Methods
, vol.9
, pp. 676-682
-
-
Schindelin, J.1
Arganda-Carreras, I.2
Frise, E.3
-
19
-
-
79960204200
-
Measurement of plasma amino acids by ultraperformance liquid chromatography
-
COI: 1:CAS:528:DC%2BC3MXhtVKqtLnE, PID: 21722078
-
Narayan SB, Ditewig-Meyers G, Graham KS, Scott R, Bennett MJ (2011) Measurement of plasma amino acids by ultraperformance liquid chromatography. Clin Chem Lab Med 49:1177–1185
-
(2011)
Clin Chem Lab Med
, vol.49
, pp. 1177-1185
-
-
Narayan, S.B.1
Ditewig-Meyers, G.2
Graham, K.S.3
Scott, R.4
Bennett, M.J.5
-
20
-
-
0032480888
-
Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP
-
PID: 9853756
-
de Rooij J, Zwartkruis FJ, Verheijen MH et al (1998) Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396:474–477
-
(1998)
Nature
, vol.396
, pp. 474-477
-
-
de Rooij, J.1
Zwartkruis, F.J.2
Verheijen, M.H.3
-
21
-
-
24144444059
-
Epac1 regulates integrity of endothelial cell junctions through VE-cadherin
-
COI: 1:CAS:528:DC%2BD2MXpvV2rurk%3D, PID: 16115630
-
Kooistra MR, Corada M, Dejana E, Bos JL (2005) Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett 579:4966–4972
-
(2005)
FEBS Lett
, vol.579
, pp. 4966-4972
-
-
Kooistra, M.R.1
Corada, M.2
Dejana, E.3
Bos, J.L.4
-
22
-
-
79955789030
-
Rap-linked cAMP signaling Epac proteins: compartmentation, functioning and disease implications
-
COI: 1:CAS:528:DC%2BC3MXmtFygt7o%3D, PID: 21402149
-
Breckler M, Berthouze M, Laurent AC, Crozatier B, Morel E, Lezoualc’h F (2011) Rap-linked cAMP signaling Epac proteins: compartmentation, functioning and disease implications. Cell Signal 23:1257–1266
-
(2011)
Cell Signal
, vol.23
, pp. 1257-1266
-
-
Breckler, M.1
Berthouze, M.2
Laurent, A.C.3
Crozatier, B.4
Morel, E.5
Lezoualc’h, F.6
-
23
-
-
84862687124
-
VE-cadherin trans-interactions modulate Rac activation and enhancement of lung endothelial barrier by iloprost
-
COI: 1:CAS:528:DC%2BC38XovVGmtbc%3D, PID: 22213015
-
Birukova AA, Tian Y, Dubrovskyi O et al (2012) VE-cadherin trans-interactions modulate Rac activation and enhancement of lung endothelial barrier by iloprost. J Cell Physiol 227:3405–3416
-
(2012)
J Cell Physiol
, vol.227
, pp. 3405-3416
-
-
Birukova, A.A.1
Tian, Y.2
Dubrovskyi, O.3
-
24
-
-
84900547141
-
Drug delivery to the back of the eye following topical administration: an update on research and patenting activity
-
COI: 1:CAS:528:DC%2BC2cXos1Gqtr4%3D, PID: 24475918
-
Boddu SHS, Gupta H, Patel S (2014) Drug delivery to the back of the eye following topical administration: an update on research and patenting activity. Recent Pat Drug Deliv Formul 8:27–36
-
(2014)
Recent Pat Drug Deliv Formul
, vol.8
, pp. 27-36
-
-
Boddu, S.H.S.1
Gupta, H.2
Patel, S.3
-
25
-
-
85019559864
-
GLP-1 as a target for the treatment of diabetic retinopathy: friend or foe?
-
Simó R, Hernández C (2017) GLP-1 as a target for the treatment of diabetic retinopathy: friend or foe? Diabetes 66:1–8
-
(2017)
Diabetes
, vol.66
, pp. 1-8
-
-
Simó, R.1
Hernández, C.2
-
26
-
-
85006173480
-
The DPP4 inhibitor linagliptin protects from experimental diabetic retinopathy
-
PID: 27942008
-
Dietrich N, Kolibabka M, Busch S et al (2016) The DPP4 inhibitor linagliptin protects from experimental diabetic retinopathy. PLoS One 11:e0167853
-
(2016)
PLoS One
, vol.11
-
-
Dietrich, N.1
Kolibabka, M.2
Busch, S.3
-
27
-
-
84903899012
-
Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2
-
COI: 1:CAS:528:DC%2BC2cXht1Oru77K, PID: 24928308
-
Wronkowitz N, Görgens SW, Romacho T et al (2014) Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2. Biochim Biophys Acta 1842:1613–1621
-
(2014)
Biochim Biophys Acta
, vol.1842
, pp. 1613-1621
-
-
Wronkowitz, N.1
Görgens, S.W.2
Romacho, T.3
-
28
-
-
84942988245
-
Identification of novel dipeptidyl peptidase 9 substrates by two-dimensional differential in-gel electrophoresis
-
COI: 1:CAS:528:DC%2BC2MXht1Krt7zI, PID: 26175140
-
Zhang H, Maqsudi S, Rainczuk A et al (2015) Identification of novel dipeptidyl peptidase 9 substrates by two-dimensional differential in-gel electrophoresis. FEBS J 282:3737–3757
-
(2015)
FEBS J
, vol.282
, pp. 3737-3757
-
-
Zhang, H.1
Maqsudi, S.2
Rainczuk, A.3
-
29
-
-
84859444000
-
Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood-retinal barrier in a type 2 diabetes animal model
-
PID: 22151893
-
Gonçalves A, Leal E, Paiva A et al (2012) Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood-retinal barrier in a type 2 diabetes animal model. Diabetes Obes Metab 14:454–463
-
(2012)
Diabetes Obes Metab
, vol.14
, pp. 454-463
-
-
Gonçalves, A.1
Leal, E.2
Paiva, A.3
-
30
-
-
84888212579
-
Beneficial effects of vildagliptin on retinal injury in obese type 2 diabetic rats
-
COI: 1:CAS:528:DC%2BC3sXhslCmt7bL, PID: 24081217
-
Maeda S, Yamagishi S, Matsui T et al (2013) Beneficial effects of vildagliptin on retinal injury in obese type 2 diabetic rats. Ophthalmic Res 50:221–226
-
(2013)
Ophthalmic Res
, vol.50
, pp. 221-226
-
-
Maeda, S.1
Yamagishi, S.2
Matsui, T.3
-
31
-
-
84903487864
-
Dipeptidyl peptidase-IV inhibition prevents blood retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats
-
PID: 24769045
-
Gonçalves A, Marques C, Leal E et al (2014) Dipeptidyl peptidase-IV inhibition prevents blood retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats. Biochim Biophys Acta 1842:1454–1463
-
(2014)
Biochim Biophys Acta
, vol.1842
, pp. 1454-1463
-
-
Gonçalves, A.1
Marques, C.2
Leal, E.3
-
32
-
-
84978110502
-
Dipeptidyl peptidase-4 inhibitor increases vascular leakage in retina through VE-cadherin phosphorylation
-
COI: 1:CAS:528:DC%2BC28XhtFGmu7nJ, PID: 27381080
-
Lee CS, Kim YG, Cho HJ et al (2016) Dipeptidyl peptidase-4 inhibitor increases vascular leakage in retina through VE-cadherin phosphorylation. Sci Rep 6:29393
-
(2016)
Sci Rep
, vol.6
, pp. 29393
-
-
Lee, C.S.1
Kim, Y.G.2
Cho, H.J.3
-
33
-
-
84892386243
-
Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes
-
PID: 24423149
-
Ott C, Raff U, Schmidt S et al (2014) Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes. Cardiovasc Diabetol 13:19
-
(2014)
Cardiovasc Diabetol
, vol.13
, pp. 19
-
-
Ott, C.1
Raff, U.2
Schmidt, S.3
-
34
-
-
84994813253
-
Semaglutide in cardiovascular outcomes in patients with type 2 diabetes
-
COI: 1:CAS:528:DC%2BC28XhvF2ksrfK, PID: 27633186
-
Marso SP, Bain SC, Consoli A et al (2016) Semaglutide in cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 375:1834–1844
-
(2016)
N Engl J Med
, vol.375
, pp. 1834-1844
-
-
Marso, S.P.1
Bain, S.C.2
Consoli, A.3
-
35
-
-
64449087059
-
Protection of exendin-4 analogue in early experimental diabetic retinopathy
-
COI: 1:CAS:528:DC%2BD1MXjvFOiu7Y%3D, PID: 19084986
-
Zhang Y, Wang Q, Zhang J, Lei X, Xu G-T, Ye W (2009) Protection of exendin-4 analogue in early experimental diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 247:699–706
-
(2009)
Graefes Arch Clin Exp Ophthalmol
, vol.247
, pp. 699-706
-
-
Zhang, Y.1
Wang, Q.2
Zhang, J.3
Lei, X.4
Xu, G.-T.5
Ye, W.6
-
36
-
-
79952230999
-
Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats
-
COI: 1:CAS:528:DC%2BC3MXmsVShtb8%3D, PID: 20688733
-
Zhang Y, Zhang J, Wang Q et al (2011) Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats. Invest Ophthalmol Vis Sci 52:278–285
-
(2011)
Invest Ophthalmol Vis Sci
, vol.52
, pp. 278-285
-
-
Zhang, Y.1
Zhang, J.2
Wang, Q.3
-
37
-
-
84865250066
-
Protection of exenatide for retinal ganglion cells with different glucose concentrations
-
PID: 22727809
-
Fu Z, Kuang HY, Hao M, Gao XY, Liu Y, Shao N (2012) Protection of exenatide for retinal ganglion cells with different glucose concentrations. Peptides 37:25–31
-
(2012)
Peptides
, vol.37
, pp. 25-31
-
-
Fu, Z.1
Kuang, H.Y.2
Hao, M.3
Gao, X.Y.4
Liu, Y.5
Shao, N.6
-
38
-
-
84908703140
-
Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2/Bax and Bcl-xL/Bax ratios and reducing reactive gliosis
-
Fan Y, Liu K, Wang Q, Ruan Y, Zhang Y, Ye W (2014) Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2/Bax and Bcl-xL/Bax ratios and reducing reactive gliosis. Mol Vis 10:1557–1568
-
(2014)
Mol Vis
, vol.10
, pp. 1557-1568
-
-
Fan, Y.1
Liu, K.2
Wang, Q.3
Ruan, Y.4
Zhang, Y.5
Ye, W.6
-
39
-
-
84905275412
-
Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats
-
COI: 1:CAS:528:DC%2BC2cXht1ymurrI, PID: 24910901
-
Fan Y, Liu K, Wang Q, Ruan Y, Ye W, Zhang Y (2014) Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats. Exp Eye Res 127:104–116
-
(2014)
Exp Eye Res
, vol.127
, pp. 104-116
-
-
Fan, Y.1
Liu, K.2
Wang, Q.3
Ruan, Y.4
Ye, W.5
Zhang, Y.6
-
40
-
-
84989952584
-
The glucagon like peptide 1 analogue, exendin-4, attenuated oxidative stress-induced retinal cell death in early diabetic rats through promoting Sirt1 and Sirt3 expression
-
COI: 1:CAS:528:DC%2BC28XhsFyrurbJ, PID: 27212443
-
Zeng Y, Yang K, Wang F et al (2016) The glucagon like peptide 1 analogue, exendin-4, attenuated oxidative stress-induced retinal cell death in early diabetic rats through promoting Sirt1 and Sirt3 expression. Exp Eye Res 151:203–211
-
(2016)
Exp Eye Res
, vol.151
, pp. 203-211
-
-
Zeng, Y.1
Yang, K.2
Wang, F.3
-
41
-
-
0031729874
-
Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial
-
The Diabetes Control and Complications Trial Research Group (1998) Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol 116:874–886
-
(1998)
Arch Ophthalmol
, vol.116
, pp. 874-886
-
-
|